Mednax Free Cash Flow Per Share from 2010 to 2024

MD Stock  USD 9.04  0.14  1.57%   
Mednax's Free Cash Flow Per Share is decreasing over the years with slightly volatile fluctuation. Overall, Free Cash Flow Per Share is expected to go to 1.38 this year. Free Cash Flow Per Share is the amount of cash Mednax Inc generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
1.23779394
Current Value
1.38
Quarterly Volatility
1.48537154
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.2 M, Interest Expense of 24.4 M or Total Revenue of 1.5 B, as well as many exotic indicators such as Price To Sales Ratio of 0.37, Dividend Yield of 0.0 or PTB Ratio of 0.87. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
This module can also supplement Mednax's financial leverage analysis and stock options assessment as well as various Mednax Technical models . Check out the analysis of Mednax Correlation against competitors.

Latest Mednax's Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of Mednax Inc over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Mednax's Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

Mednax Free Cash Flow Per Share Regression Statistics

Arithmetic Mean2.67
Geometric Mean1.98
Coefficient Of Variation55.60
Mean Deviation1.24
Median2.65
Standard Deviation1.49
Sample Variance2.21
Range4.9068
R-Value(0.29)
Mean Square Error2.18
R-Squared0.08
Significance0.30
Slope(0.1)
Total Sum of Squares30.89

Mednax Free Cash Flow Per Share History

2024 1.38
2023 1.24
2022 1.64
2021 0.52
2020 2.11
2019 3.77
2018 2.65

About Mednax Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Mednax income statement, its balance sheet, and the statement of cash flows. Mednax investors use historical funamental indicators, such as Mednax's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Mednax investors may use each financial statement separately, they are all related. The changes in Mednax's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mednax's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mednax Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mednax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share 1.24  1.38 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mednax in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mednax's short interest history, or implied volatility extrapolated from Mednax options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Mednax Inc is a strong investment it is important to analyze Mednax's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mednax's future performance. For an informed investment choice regarding Mednax Stock, refer to the following important reports:
Check out the analysis of Mednax Correlation against competitors.
Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Mednax Stock analysis

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.31)
Revenue Per Share
24.265
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0432
Return On Equity
(0.07)
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.